CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemia.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 12846892)

Published in Br J Haematol on July 01, 2003

Authors

Richard Aplenc1, Wendy Glatfelter, Peggy Han, Eric Rappaport, Mei La, Avital Cnaan, M Anne Blackwood, Beverly Lange, Timothy Rebbeck

Author Affiliations

1: Children's Hospital of Philadelphia, Philadelphia, University of Pennsylvania, PA, Children's Cancer Study Group, Arcadia, CA, USA. replenc@cceb.upenn.edu

Articles by these authors

Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature (2009) 7.39

Identification of ALK as a major familial neuroblastoma predisposition gene. Nature (2008) 7.38

Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica (2004) 5.21

Cornelia de Lange syndrome is caused by mutations in NIPBL, the human homolog of Drosophila melanogaster Nipped-B. Nat Genet (2004) 5.19

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet (2010) 4.96

Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA (2007) 4.44

Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities. Am J Public Health (2008) 3.98

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med (2010) 3.86

ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia (2006) 3.69

Communication of randomization in childhood leukemia trials. JAMA (2004) 3.20

What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood (2008) 3.03

Transcriptional dysregulation in NIPBL and cohesin mutant human cells. PLoS Biol (2009) 2.89

Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med (2006) 2.88

A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. Blood (2002) 2.76

MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst (2005) 2.57

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma. Nat Genet (2009) 2.47

Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major. Blood (2005) 2.45

TOX: an HMG box protein implicated in the regulation of thymocyte selection. Nat Immunol (2002) 2.44

Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer Res (2006) 2.42

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group. Blood (2009) 2.36

Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers. Cancer Res (2002) 2.25

Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury. Pediatr Nephrol (2006) 2.09

A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics (2008) 2.08

Enhancing their likelihood for a positive future: the perspective of inner-city youth. Pediatrics (2002) 2.06

Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial. JAMA (2003) 2.04

Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891. J Clin Oncol (2003) 1.93

Application of a BRAF pyrosequencing assay for mutation detection and copy number analysis in malignant melanoma. J Mol Diagn (2007) 1.85

Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961. J Pediatr Hematol Oncol (2004) 1.80

Non-enteropathic hemolytic uremic syndrome: causes and short-term course. Am J Kidney Dis (2004) 1.71

Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia (2013) 1.69

Germline PHOX2B mutation in hereditary neuroblastoma. Am J Hum Genet (2004) 1.66

Basic fibroblast growth factor among children with diarrhea-associated hemolytic uremic syndrome. J Am Soc Nephrol (2002) 1.63

Screening for risk of persistent posttraumatic stress in injured children and their parents. JAMA (2003) 1.56

The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures. Muscle Nerve (2013) 1.55

U-statistics-based tests for multiple genes in genetic association studies. Ann Hum Genet (2008) 1.53

Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy. Neurology (2013) 1.52

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet (2011) 1.51

Treatment of posttraumatic stress symptoms in adolescent survivors of childhood cancer and their families: a randomized clinical trial. J Fam Psychol (2004) 1.49

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Epilepsia (2012) 1.49

Injury reduction effectiveness of assigning running shoes based on plantar shape in Marine Corps basic training. Am J Sports Med (2010) 1.48

The cooperative international neuromuscular research group Duchenne natural history study--a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used. Muscle Nerve (2013) 1.48

Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group. Blood (2006) 1.48

Multiple courses of antenatal corticosteroids are associated with early severe lung disease in preterm neonates. J Perinatol (2002) 1.41

Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood (2003) 1.40

Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children's oncology group. Cancer Epidemiol Biomarkers Prev (2005) 1.39

Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood (2011) 1.39

Rapid detection of submicroscopic chromosomal rearrangements in children with multiple congenital anomalies using high density oligonucleotide arrays. Hum Mutat (2006) 1.31

Acute stress disorder symptoms in children and their parents after pediatric traffic injury. Pediatrics (2002) 1.29

Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibition. Blood (2004) 1.27

WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group. J Clin Oncol (2010) 1.26

TOX provides a link between calcineurin activation and CD8 lineage commitment. J Exp Med (2004) 1.24

Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor. Cancer Res (2005) 1.23

One-year respiratory outcomes of preterm infants enrolled in the Nitric Oxide (to prevent) Chronic Lung Disease trial. J Pediatr (2008) 1.21

Clinical and genetic risk factors of self-reported penicillin allergy. J Allergy Clin Immunol (2008) 1.21

Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome. Br J Haematol (2009) 1.20

Reading level of Medicaid renewal applications. Acad Pediatr (2012) 1.20

Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group. Pediatr Blood Cancer (2007) 1.18

Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial. Blood (2010) 1.17

Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group. Blood (2010) 1.16

Pretreatment EEG in childhood absence epilepsy: associations with attention and treatment outcome. Neurology (2013) 1.15

Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia. Cancer Res (2005) 1.13

Dysfunction of pulmonary surfactant in chronically ventilated premature infants. Pediatr Res (2004) 1.12

Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J Clin Oncol (2004) 1.11

Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2006) 1.11

Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with advanced CD33+ acute myeloid leukemia. Blood (2005) 1.08

Supervised multi-view canonical correlation analysis (sMVCCA): integrating histologic and proteomic features for predicting recurrent prostate cancer. IEEE Trans Med Imaging (2014) 1.07

Ganglion cell layer-inner plexiform layer thickness and vision loss in young children with optic pathway gliomas. Invest Ophthalmol Vis Sci (2014) 1.07

BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic. J Clin Oncol (2002) 1.06

Elevated substance P levels in HIV-infected women in comparison to HIV-negative women. AIDS Res Hum Retroviruses (2008) 1.04

Corticosterone suppresses cutaneous immune function in temperate but not tropical House Sparrows, Passer domesticus. Gen Comp Endocrinol (2004) 1.02

Genetic modifiers of ambulation in the Cooperative International Neuromuscular Research Group Duchenne Natural History Study. Ann Neurol (2015) 1.01

Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy. Epilepsia (2005) 1.00

Accounting for multiple births in neonatal and perinatal trials: systematic review and case study. J Pediatr (2009) 1.00

Postrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group. Blood (2010) 1.00

Patterns of posttraumatic stress symptoms in parents of childhood cancer survivors. J Fam Psychol (2005) 0.99

Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells. J Immunol (2005) 0.99

Maternal supplement, micronutrient, and cured meat intake during pregnancy and risk of medulloblastoma during childhood: a children's oncology group study. Cancer Epidemiol Biomarkers Prev (2006) 0.98

Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials. J Clin Oncol (2004) 0.97

Plasma biomarkers of oxidative stress: relationship to lung disease and inhaled nitric oxide therapy in premature infants. Pediatrics (2008) 0.95

Region-specific detection of neuroblastoma loss of heterozygosity at multiple loci simultaneously using a SNP-based tag-array platform. Genome Res (2005) 0.95

Maternal diet during pregnancy and its association with medulloblastoma in children: a children's oncology group study (United States). Cancer Causes Control (2005) 0.93

Special education services and school performance in a regional cohort of low-birthweight infants at age nine. Paediatr Perinat Epidemiol (2004) 0.93

Serial transcriptome analysis and cross-species integration identifies centromere-associated protein E as a novel neuroblastoma target. Cancer Res (2010) 0.93

The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progression. J Neurooncol (2007) 0.91

Association of hypertension genotypes and decline in renal function after kidney transplantation. Transplantation (2007) 0.90

Comparison of embedded and isolated administrations of the California Psychological Inventory's Socialization subscale. Psychol Assess (2003) 0.90

Maternal health literacy and late initiation of immunizations among an inner-city birth cohort. Matern Child Health J (2011) 0.90

Detection of full-length and truncated neurokinin-1 receptor mRNA expression in human brain regions. J Neurosci Methods (2007) 0.89

Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia. Br J Haematol (2004) 0.89

Association of metabolic gene polymorphisms with tobacco consumption in healthy controls. Int J Cancer (2004) 0.89

Primary respiratory chain disease causes tissue-specific dysregulation of the global transcriptome and nutrient-sensing signaling network. PLoS One (2013) 0.88

Reduced folate carrier and dihydrofolate reductase expression in acute lymphocytic leukemia may predict outcome: a Children's Cancer Group Study. J Pediatr Hematol Oncol (2003) 0.88

Molecular karyotype of sporadic unilateral retinoblastoma tumors. Retina (2009) 0.87

Economic evaluation of inhaled nitric oxide in preterm infants undergoing mechanical ventilation. Pediatrics (2009) 0.87

Inflammatory markers and mediators in tracheal fluid of premature infants treated with inhaled nitric oxide. Pediatrics (2007) 0.87

An evaluation of the efficacy and tolerability of oral tramadol hydrochloride tablets for the treatment of postsurgical pain in children. Anesth Analg (2002) 0.86